Improved Uranium Pricing Supports Cameco Corporation (CCJ) Through Short-Term Production Headwinds; TD Securities Remains Bullish

With significant hedge fund interest, Cameco Corporation (NYSE:CCJ) secures a spot on our list of the 12 best commodity stocks to buy right now.

On November 13, The Fly reported that TD Securities raised its price target on Cameco Corporation (NYSE:CCJ) from C$142 to C$150, reiterating its “Buy” rating.

Meanwhile, on November 5, 2025, Cameco Corporation (NYSE:CCJ) reported its Q3 2025 results. The quarter marked $615 million in revenue, beating forecasts by 8.3%, but lower by 15% on a YoY basis. Cameco Corporation (NYSE:CCJ) recorded $32 million, or $0.07 a share in adjusted earnings for the quarter, missing expectations. The earnings shortfall was attributed to reduced production at key sites, including MacArthur River and Key Lake. Meanwhile, cash and liquidity totaled $779 million, well supported by a $1 billion undrawn credit facility. During the quarter, the company also announced an increase in its dividend to $0.24 per common share.

While the company reduced its production guidance, Cameco Corporation (NYSE:CCJ)’s management remains confident, citing upside from improved uranium pricing, a robust sales pipeline, and ongoing operational flexibility through standby loan facilities. Furthermore, the company expects to accelerate reactor deliveries through its partnership with Westinghouse.

Cameco Corporation (NYSE:CCJ) is focused on uranium production for electricity generation.

While we acknowledge the potential of CCJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Small-Cap Biotech Stocks to Buy According to Analysts and 11 Best AI Infrastructure Stocks to Buy Right Now.

Disclosure: None.